Karamzadeh A, Heidari M, Namazi A, Tabaeian S, Akbari A
Mol Biol Rep. 2024; 51(1):1109.
PMID: 39476151
DOI: 10.1007/s11033-024-10020-x.
Gluba-Sagr A, Franczyk B, Rysz-Gorzynska A, Olszewski R, Rysz J
Int J Mol Sci. 2024; 25(17).
PMID: 39273193
PMC: 11395304.
DOI: 10.3390/ijms25179244.
Yao Y, Zhang Q, Wei S, Li H, Zhou T, Zhang Q
Transl Cancer Res. 2024; 13(6):2913-2937.
PMID: 38988945
PMC: 11231768.
DOI: 10.21037/tcr-23-2243.
Liu Y, Du M, Zhang L, Wang N, He Q, Cao J
Animals (Basel). 2024; 14(12).
PMID: 38929336
PMC: 11200857.
DOI: 10.3390/ani14121717.
Su Y, Liu J, Wu Q, Gao Z, Wang J, Li H
Interdiscip Sci. 2024; 16(3):608-622.
PMID: 38581626
DOI: 10.1007/s12539-024-00610-5.
Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.
Yang F, Zhou L, Shen Y, Wang X, Fan X, Yang L
J Transl Med. 2024; 22(1):214.
PMID: 38424613
PMC: 10902991.
DOI: 10.1186/s12967-024-05029-6.
Long Non-Coding RNAs (lncRNAs) in Heart Failure: A Comprehensive Review.
Jha S, Loganathbabu V, Kumaran K, Krishnasamy G, Aruljothi K
Noncoding RNA. 2024; 10(1).
PMID: 38250803
PMC: 10801533.
DOI: 10.3390/ncrna10010003.
LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea.
Chen K, Ou B, Huang Q, Deng D, Xiang Y, Hu F
Epigenetics. 2024; 19(1):2293409.
PMID: 38232183
PMC: 10795783.
DOI: 10.1080/15592294.2023.2293409.
The expression and function of long noncoding RNAs in hepatocellular carcinoma.
Du J, Su Y, Gao J, Tai Y
Cancer Innov. 2023; 2(6):488-499.
PMID: 38125766
PMC: 10730004.
DOI: 10.1002/cai2.90.
LncRNA CFRL aggravates cardiac fibrosis by modulating both miR-3113-5p/CTGF and miR-3473d/FN1 axis.
Cui Y, Shi B, Zhou Z, Chen B, Zhang X, Li C
iScience. 2023; 26(10):108039.
PMID: 37954142
PMC: 10638480.
DOI: 10.1016/j.isci.2023.108039.
Identification of Key lncRNAs, circRNAs, and mRNAs in Osteoarthritis via Bioinformatics Analysis.
Zhang W, Wei C, Wang L
Mol Biotechnol. 2023; 66(7):1660-1672.
PMID: 37382793
DOI: 10.1007/s12033-023-00790-3.
LncRNA LINC01569 promotes M2 macrophage polarization to accelerate hypopharyngeal carcinoma progression through the miR-193a-5p/FADS1 signaling axis.
Gong Q, Li H, Song J, Lin C
J Cancer. 2023; 14(9):1673-1688.
PMID: 37325064
PMC: 10266250.
DOI: 10.7150/jca.83466.
MncR: Late Integration Machine Learning Model for Classification of ncRNA Classes Using Sequence and Structural Encoding.
Dunkel H, Wehrmann H, Jensen L, Kuss A, Simm S
Int J Mol Sci. 2023; 24(10).
PMID: 37240230
PMC: 10218863.
DOI: 10.3390/ijms24108884.
lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway.
Kang H, Huang D, Li H, Deng X, Liu S, Gou W
Bioengineered. 2023; 13(7-12):15003-15012.
PMID: 37105761
PMC: 10234215.
DOI: 10.1080/21655979.2023.2180591.
Identification of biomarkers of hepatocellular carcinoma gene prognosis based on the immune-related lncRNA signature of transcriptome data.
Ma A, Sun Y, Ogbodu R, Xiao L, Deng H, Zhou H
Funct Integr Genomics. 2023; 23(2):104.
PMID: 36976410
DOI: 10.1007/s10142-023-01019-x.
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
Zhong L, Zhu J, Shu Q, Xu G, He C, Fang L
J Oncol. 2023; 2023:5925935.
PMID: 36844874
PMC: 9957631.
DOI: 10.1155/2023/5925935.
LncRNA MALAT1 Regulates Hyperglycemia Induced EMT in Keratinocyte via miR-205.
Zhang L, Hung G, Meng S, Evans R, Xu J
Noncoding RNA. 2023; 9(1).
PMID: 36827547
PMC: 9963368.
DOI: 10.3390/ncrna9010014.
LncRNA Induced Non-Small Cell Lung Cancer Development through Up-Regulating CDK6 by Sponge Adsorption of miRNA-204.
Yu X, Liu D, Wang L, Wang L
Iran J Public Health. 2023; 51(9):2117-2127.
PMID: 36743367
PMC: 9884374.
DOI: 10.18502/ijph.v51i9.10567.
lncRNA SSTR5-AS1 Predicts Poor Prognosis and Contributes to the Progression of Esophageal Cancer.
Hu Y, Mao N, Zheng W, Hong B, Deng X
Dis Markers. 2023; 2023:5025868.
PMID: 36726845
PMC: 9886483.
DOI: 10.1155/2023/5025868.
LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis.
Liu J, Jiang M, Guan J, Wang Y, Yu W, Hu Y
J Thorac Dis. 2022; 14(10):4081-4095.
PMID: 36389338
PMC: 9641317.
DOI: 10.21037/jtd-22-1261.